Bemarituzumab Biosimilar (FGFR2 / CD332 Reference Antibody)
Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor) . Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research.
Product Specifications
Target
Bemarituzumab Biosimilar (Anti-FGFR2 / CD332 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation; Cell Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15173446 1 Vial
Lentiviral mouse Zfp708 shRNA (UAS) - Lentiviral mouse Zfp708 shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details 
MBS6141195-01 0.1 mL
CHRNB3 (Neuronal Acetylcholine Receptor Subunit beta-3) (Biotin)
Sign In for Pricing
View Details MBS6141195-02 5x 0.1 mL
CHRNB3 (Neuronal Acetylcholine Receptor Subunit beta-3) (Biotin)
Sign In for Pricing
View Details MBS1583040-01 50 Tests
Anti-Human CD140b/PDGFRB Antibody (28D4), PerCP
Sign In for Pricing
View Details MBS1583040-02 100 Tests
Anti-Human CD140b/PDGFRB Antibody (28D4), PerCP
Sign In for Pricing
View Details